Cipla Gets USFDA Approval for Generic Cancer Drug
April 11, 2025 11:31
Cipla receives USFDA approval for its generic cancer treatment drug, paclitaxel protein-bound particles, a therapeutic equivalent to Bristol Myers Squibb's Abraxane. The drug is expected to launch...